Rationale: Whether short-term glucose control in cystic fibrosis-related diabetes (CFRD) is associated with FEV1 recovery during acute pulmonary exacerbations is unclear.
Methods: Data from all patients with CFRD ages 6-21 years hospitalized in 2010-2016 for pulmonary exacerbations at our CF Center were analyzed, including CFRD status at each encounter, all FEV1 recorded during each exacerbation, and relevant clinical covariates. Glucose control was analyzed using meter blood glucose area under the curve (AUC) indices. The primary outcome was FEV1 recovery.
Results: Patients with CFRD who finished IV antibiotics at home were treated for longer than those fully treated in the hospital (22.2 vs. 13.8 days). In those who finished treatment at home, poor inpatient glycemic control was associated with lower lung function improvement: when comparing the 75th to the 25th percentile of each glycemic index (i.e., "poorer" vs. "better" glycemic control), FEV1 recovery at discharge was 20.1% lower for glucose AUC (95%CI -0.4%, -39.9%); 20.9% lower for 48-h AUC (95%CI -2.7%, -39.1%); and 28.2% lower for AUC/day (95%CI -7.1%, -49.3%). Similar results were found at the end of IV antibiotics and at clinic follow-up. Likewise, patients with poor glycemic control had a lower slope of inpatient FEV1 recovery. Analysis in patients with normal glucose tolerance was largely non-significant. No associations were found between hemoglobin A1c and FEV1 recovery.
Conclusions: In patients with CFRD who complete IV antibiotic treatment at home, poor inpatient glycemic control is associated with worse FEV1 recovery despite longer duration of treatment.
Keywords: Cystic fibrosis; Cystic fibrosis-related diabetes; Glycemic control; Lung function.
Copyright © 2020. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors have no competing interests to declare.
Elevation of One Hour Plasma Glucose During Oral Glucose Tolerance TestingS Sheikh et al. Pediatr Pulmonol 50 (10), 963-9. PMID 26087115.The risk of CFRD increases with PG1 > 160 mg/dl. No statistically significant evidence of an association between elevated PG1 and pulmonary function was found, yet our …
Cystic Fibrosis-Related Diabetes With Strict Glycaemic Control Is Not Associated With Frequent Intravenous Antibiotics Use for Pulmonary InfectionsG Belle-van Meerkerk et al. Diabetes Res Clin Pract 116, 230-6. PMID 27321340.In this cohort with overall strict glycaemic control, the frequency of IV antibiotics use was related to chronic infection and impaired lung function at baseline, but not …
Sputum Glucose and Glycemic Control in Cystic Fibrosis-Related Diabetes: A Cross-Sectional StudyL Van Sambeek et al. PLoS One 10 (3), e0119938. PMID 25803537.Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated with increased mortality and more frequent pulmonary exacerbations. Howe …
Clinical Updates in Cystic Fibrosis-Related DiabetesAL Brennan et al. Semin Respir Crit Care Med 36 (2), 236-50. PMID 25826591. - ReviewImproved clinical care has led to a dramatic increase in life expectancy for people with cystic fibrosis (CF). As they live longer, people with CF are therefore developin …
Nebulised Hypertonic Saline for Cystic FibrosisP Wark et al. Cochrane Database Syst Rev 9 (9), CD001506. PMID 30260472. - ReviewRegular use of nebulised hypertonic saline by adults and children over the age of 12 years with CF results in an improvement in lung function after four weeks (very low-q …